Sermorelin: the GHRH analog that used to be FDA approved
Research & educational use only. This content is not medical advice. Consult a qualified healthcare professional before using any peptide compound.
Something a lot of people do not realize: sermorelin (GHRH 1-29) was previously marketed in the US as Geref before being discontinued as a finished product. It is now mostly available through compounding pharmacies.
So unlike most research peptides, there is genuine historical clinical and diagnostic human use behind it. It still is not a currently approved marketed drug, but its background is different from the pure gray-market compounds.